Management at Rite Aid Corporation (RAD) was executing a turnaround strategy centered on increasing the profitability of the existing store base. However, the acquisition of Brooks Eckerd prior to a convincing turnaround in profitability has increased the debt burden and interest expense.

Moreover, Wal-Mart’s foray into the retail generic drug market has pressured the company’s pharmacy margin.

Given the weakness of front-end sales and management’s continual lowering of EPS guidance (for larger net losses), the stock’s rating remains Underperform.

Zacks Investment Research
View original at: Zacks.com News Feed

1. (CNMD) Conmed Corporation – Bear of the DayConmed (CNMD) operates in highly competitive markets against competitors that are much larger, technically competent...
2. (RAD) Rite Aid Corporation – Bear of the DayManagement at Rite Aid Corporation (RAD) was executing a turnaround strategy centered on increasing the...
3. (ODP) Office Depot Introduces Flu KitOffice Depot Inc. (ODP), the global supplier of a range of office products and services,...
4. (PGR) Progressive Corporation: Earnings PreviewProgressive Corp. (PGR) is expected to release its third quarter results before the market opens...
5. (PSS) Collective Brands Reports In-Line with EstimatesAmid a sluggish retail environment, Collective Brands, Inc. (PSS), a wholesaler and retailer of footwear...
6. (BAC) Bank of America Befriends a BearBank of America Befriends a Bear Today, Bank of America (NYSE: BAC) announced it could...

Search Posts by Tag: RAD | Rite Aid Corporation | Drug Stores | Services

RSS Feeds by Tag: RAD | Rite Aid Corporation | Drug Stores | Services |

Other Posts by: vitalstocks | RSS Feed for this author